Healthcare Global Enterprises Ltd.
NSE: HCG | BSE: 539787
₹646.85
₹14.60
(2.31%)
As on 19-May-2026 15:47IST
Market cap
₹9,632 Cr
Revenue (TTM)
₹2,478 Cr
P/E Ratio
508.3
P/B Ratio
7.2
Div. Yield
0 %
Quality Score
1/10
Growth Score
7/10
Valuation Score
2/10
Momentum Score
7/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹19 Cr
-
ROE
5.7 %
-
ROCE
12.4 %
-
Industry P/E
53.26
-
EV/EBITDA
22.1
-
Debt to Equity
1.1
-
Book Value
₹89.6
-
EPS
₹2.8
-
Face value
10
-
Shares outstanding
149,302,203
10 Years Aggregate
CFO
₹1,684.86 Cr
EBITDA
₹1,938.97 Cr
Net Profit
₹-188.49 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Healthcare Global
| -1.7 | 14.4 | 9.0 | 9.6 | 28.0 | 28.0 | 13.3 |
|
BSE Healthcare
| 9.5 | 9.4 | 9.8 | 12.1 | 27.6 | 14.5 | 11.8 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Healthcare Global
| 36.5 | 33.9 | 27.2 | 20.2 | 45.5 | 56.1 | -46.3 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Healthcare Global
|
646.9 | 9,632.2 | 2,478.2 | 24.7 | 8.4 | 4.2 | 508.3 | 7.2 |
| 275.2 | 4,376.4 | 1,081.2 | 103.7 | 13.0 | 11.7 | 42.2 | 5.1 | |
| 748.9 | 38,659.6 | 4,643.2 | 464.1 | 13.7 | 8.9 | 99.6 | 8.4 | |
| 456.9 | 14,416.8 | 1,976.2 | 160.7 | 14.1 | 6.7 | 114.4 | 7.3 | |
| 5,107.1 | 2,468.0 | 450.7 | 69.9 | 22.1 | 26.7 | 35.3 | 7.4 | |
| 359.4 | 3,295.6 | 1,482.5 | 183.6 | 15.1 | 26.3 | 17.9 | 4.5 | |
| 1,328.9 | 8,698.6 | 1,494.5 | 194.1 | 17.1 | 13.2 | 44.8 | 5.6 | |
| 5,342.0 | 5,841.0 | 1,529.9 | 235.8 | 21.2 | 20.7 | 24.8 | 4.7 | |
| 1,350.7 | 13,745.0 | 1,613.3 | 259.9 | 23.0 | 17.3 | 53.4 | 8.6 | |
| 832.9 | 8,055.2 | 1,089.4 | 165.1 | 17.4 | 10.2 | 48.1 | 4.7 |
Shareholding Pattern
View DetailsNews & Analysis
All News
1 min read•By Research Desk
How did MFs fare as anchor investors?
4 min read•By Kumar Shankar Roy
About Healthcare Global
HealthCare Global Enterprises Limited, together with its subsidiaries, provides medical and healthcare services focusing on cancer and fertility in India and internationally. The company offers cancer diagnosis and treatment services through... radiation therapy, medical oncology, and surgery; and fertility treatment services, including reproductive medicine, assisted reproduction, gynecological endoscopy, and fertility preservation under the Milann brand. It also operates multi-specialty hospitals under the HCG brand that provides inpatient and outpatients treatments with specialties in cardiology, neurology, orthopaedics, gastroenterology, urology, internal medicine and pulmonary, and critical care. In addition, the company offers cancer diagnostic services; combining laboratory services; and research and development, and clinical research to enhance cancer diagnosis and prognosis. HealthCare Global Enterprises Limited was founded in 1989 and is headquartered in Bengaluru, India. Read more
-
Incorporated
1998
-
Chairman
B S Ajai Kumar
-
Managing Director
--
-
Group
HCG
-
Headquarters
Bengaluru, Karnataka
-
Website
Looking for more details about Healthcare Global Enterprises Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
FAQs for Healthcare Global
What is the current share price of Healthcare Global Enterprises Ltd Today?
The share price of Healthcare Global Enterprises Ltd is ₹646.85 (NSE) and ₹647.25 (BSE) as of 19-May-2026 15:47 IST. Healthcare Global Enterprises Ltd has given a return of 27.97% in the last 3 years.
What is the current PB & PE ratio of Healthcare Global Enterprises Ltd?
The P/E ratio of Healthcare Global Enterprises Ltd is 508.30 times as on 19-May-2026, a 854 premium to its peers’ median range of 53.26 times.
The P/B ratio of Healthcare Global Enterprises Ltd is 7.20 times as on 19-May-2026, a 3 discount to its peers’ median range of 7.42 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
168.91
|
8.33
|
|
2024
|
97.83
|
5.83
|
|
2023
|
123.76
|
4.31
|
|
2022
|
69.40
|
4.34
|
|
2021
|
0.00
|
3.70
|
What is the 52 Week High and Low of Healthcare Global Enterprises Ltd?
The 52-week high and low of Healthcare Global Enterprises Ltd are Rs 799.71 and Rs 513.30 as of 19-May-2026.
What is the market cap of Healthcare Global Enterprises Ltd?
Healthcare Global Enterprises Ltd has a market capitalisation of ₹ 9,632 Cr as on 19-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Healthcare Global Enterprises Ltd?
Before investing in Healthcare Global Enterprises Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.